Balaji Amines Limited announced robust financial results for the second quarter of FY27, with revenue climbing 36% year-on-year to INR472 crore. Consolidated EBITDA saw a significant increase of 58% to INR106 crore, with margins improving to 22%. Profit after tax surged by 82% to INR67 crore, and diluted EPS rose to INR20.76.
Balaji Amines Reports Strong Q2 FY27 Performance
Balaji Amines Limited has disclosed impressive financial results for the second quarter ended September 30, 2026. The company demonstrated substantial year-on-year growth across key financial metrics, underscoring its improving profitability and operational strength.
Financial Highlights for Q2 FY27
Consolidated revenue for the quarter stood at INR472 crore, marking a significant increase of approximately 36% compared to INR348 crore in the corresponding quarter of FY26. This growth was driven by increased sales volumes and a favorable product mix.
Consolidated EBITDA for the quarter reached INR106 crore, a substantial jump of about 58% from INR67 crore in Q2 FY26. The EBITDA margin improved to 22%, up from 19% in the previous year’s second quarter. Profit after tax for the quarter rose by approximately 82% to INR67 crore, compared to INR37 crore in Q2 FY26. Diluted Earnings Per Share (EPS) for the quarter was INR20.76, a notable increase from INR10.67 in the same period last year.
Half-Yearly Performance
For the first half of FY27, consolidated revenue stood at INR933 crore, up 31% from INR715 crore in H1 FY26. Consolidated EBITDA increased by 74% to INR227 crore, with margins improving to 24% from 18% year-on-year. Consolidated Profit After Tax (PAT) for H1 FY27 grew by approximately 98% to INR146 crore, compared to INR74 crore in H1 FY26.
Operational Developments
The company highlighted the commencement of commercial production at its process-improved Acetonitrile plant, with expanded capacity reaching 1,440 tons per month. Significant progress was also noted in the expansion program for Balaji Specialty Chemicals Limited, including brownfield expansion projects for EDA-based derivatives and a greenfield expansion for hydrogen cyanide, sodium cyanide, and EDTA at Unit-2, targeted for commissioning in Q4 FY27.
Developments also include the approval of Dimethyl Ether (DME) Road Tanker valves and progress on Road Tankers approval, expected within 3-4 weeks, paving the way for bulk supplies. The company is actively exploring opportunities in the DME market, particularly for aerosol applications, and is developing N-Methyl Morpholine (NMM) for its specialty chemicals portfolio.
Balance Sheet Strength
As of September 30, 2026, the consolidated net worth stood at INR 2,023.02 crore. Consolidated debt was INR161.15 crore, with cash and cash equivalents at INR52.62 crore. On a standalone basis, Balaji Amines continues to maintain a zero debt position.
Source: BSE
